Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport A 2026 technology landscape of marine current energy converters: turbine types, patent activity, geographic leaders, and emerging directions in MCEC innovation.
Article | Rapport How glecirasib, Janssen's tricyclics, and next-gen KRAS G12C combination strategies are reshaping the post-sotorasib/adagrasib oncology pipeline.
Article | Rapport How AI transforms cross-industry analogical reasoning for engineers — semantic search, knowledge graphs, and design-by-analogy systems explained.
Article | Rapport Silicon anode technology offers up to 4,200 mAh g⁻¹ capacity vs graphite's 372 mAh g⁻¹. Explore the 2026 EV silicon anode innovation landscape, key patents, and commercialisation pathways.
Article | Rapport How R&D teams structure stage-gate review processes to reduce technical risk in new material development programs — frameworks, TRL gates, and decision criteria.
Article | Rapport AstraZeneca's dapagliflozin (Farxiga) faces LOE pressure as core patents expire. Explore SGLT2 inhibitor lifecycle management, combination formulations, and pipeline strategy.
Article | Rapport ERW can remove 1–4.5 Gt CO₂/yr globally. Explore the 2026 patent landscape, MRV innovations, feedstock science, and commercial deployment signals.
Article | Rapport How AI-assisted claim mapping helps semiconductor engineers identify design freedom, navigate crowded patent landscapes, and uncover white spaces for innovation.
Article | Rapport Explore the 2026 implantable glucose sensor technology landscape: fluorescence, electrochemical, and impedance sensing, key patents, and emerging IP trends.
Article | Rapport AZD0780 (AstraZeneca) and MK-0616 (Merck) are racing to become the first oral PCSK9 small molecule inhibitor. Explore Phase III timelines, IP dynamics, and LDL-C data.
Article | Rapport Explore the 2026 bio-based polyamide technology landscape: key synthesis routes, application domains, patent filings, and emerging directions from castor oil to FDCA.
Article | Rapport How engineers use competitive patent monitoring to anticipate technology shifts in fast-moving industrial sectors — methodologies, tools, and strategic applications.
Article | Rapport MK-0616, Merck's oral PCSK9 inhibitor, enters Phase III VICTORION-ORAL. Explore the science, patent landscape, and small-molecule pipeline race for LDL-C control.
Article | Rapport How PAEK, PEEK, and PPS resin systems, fusion welding IP, and digital twins are reshaping thermoplastic composite aerospace structure manufacturing in 2026.
Article | Rapport Mirikizumab (Omvoh) IBD expansion, real-world launch data, and IL-23p19 competition with guselkumab. How Lilly's commercial ramp stacks up in 2024.